CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
repetitive Transcranial Magnetic Stimulation (rTMS)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01900314
NCT01900314N/ACompleted
CompareCT.gov

Imaging Biomarkers for TMS Treatment of Depression

University of Michigan·interventional·Posted Jul 16, 2013·Updated Apr 25, 2017

In Brief

A clinical study evaluating repetitive Transcranial Magnetic Stimulation (rTMS) for Depression. Completed, enrolled 40 participants across 1 site.

Detailed Summary

The purpose of this research is to learn more about how rTMS works to reduce the symptoms of depression. This information can be used to improve the effectiveness of the treatment. The study will use functional magnetic resonance imaging (fMRI) to examine changes in brain function after treatment with rTMS. fMRI is a safe and painless technique that allows investigators to observe the brain "at work." The investigators will use fMRI to see what regions of the brain become active when you perform a concentration task and how that activation is changed after rTMS.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH), Neuronetics

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJul 16, 2013
Enrollment StartSep 1, 2013
Primary CompletionJan 1, 2016
Study CompletionApr 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 13.0 years ago

Interventions

repetitive Transcranial Magnetic Stimulation (rTMS)device

20 active sessions, within a 4 week period, where subjects receive the same repetitive Transcranial Magnetic Stimulation (rTMS) treatment parameters as the sham arm.